vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $11.9M, roughly 1.1× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -488.0%, a 479.2% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs -22.4%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -34.9%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

ACNT vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.1× larger
OCUL
$13.3M
$11.9M
ACNT
Growing faster (revenue YoY)
ACNT
ACNT
+35.8% gap
ACNT
13.3%
-22.4%
OCUL
Higher net margin
ACNT
ACNT
479.2% more per $
ACNT
-8.8%
-488.0%
OCUL
More free cash flow
ACNT
ACNT
$56.9M more FCF
ACNT
$-196.0K
$-57.1M
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-34.9%
ACNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNT
ACNT
OCUL
OCUL
Revenue
$11.9M
$13.3M
Net Profit
$-1.0M
$-64.7M
Gross Margin
14.6%
88.0%
Operating Margin
-21.0%
-526.5%
Net Margin
-8.8%
-488.0%
Revenue YoY
13.3%
-22.4%
Net Profit YoY
-1.2%
-33.6%
EPS (diluted)
$-0.11
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
OCUL
OCUL
Q4 25
$11.9M
$13.3M
Q3 25
$19.7M
$14.5M
Q2 25
$18.7M
$13.5M
Q1 25
$24.7M
$10.7M
Q4 24
$10.5M
$17.1M
Q3 24
$20.9M
$15.4M
Q2 24
$21.5M
$16.4M
Q1 24
$28.0M
$14.8M
Net Profit
ACNT
ACNT
OCUL
OCUL
Q4 25
$-1.0M
$-64.7M
Q3 25
$-2.1M
$-69.4M
Q2 25
$6.3M
$-67.8M
Q1 25
$-2.3M
$-64.1M
Q4 24
$-1.0M
$-48.4M
Q3 24
$-6.2M
$-36.5M
Q2 24
$-926.0K
$-43.8M
Q1 24
$-5.5M
$-64.8M
Gross Margin
ACNT
ACNT
OCUL
OCUL
Q4 25
14.6%
88.0%
Q3 25
29.7%
87.8%
Q2 25
26.1%
85.6%
Q1 25
19.3%
88.2%
Q4 24
24.3%
92.8%
Q3 24
14.4%
89.9%
Q2 24
13.1%
90.8%
Q1 24
8.3%
91.0%
Operating Margin
ACNT
ACNT
OCUL
OCUL
Q4 25
-21.0%
-526.5%
Q3 25
-4.1%
-472.3%
Q2 25
-14.4%
-502.6%
Q1 25
-4.2%
-597.5%
Q4 24
-25.4%
-296.1%
Q3 24
-9.4%
-298.2%
Q2 24
-8.6%
-265.1%
Q1 24
-15.5%
-214.0%
Net Margin
ACNT
ACNT
OCUL
OCUL
Q4 25
-8.8%
-488.0%
Q3 25
-10.6%
-477.3%
Q2 25
33.7%
-503.9%
Q1 25
-9.3%
-598.7%
Q4 24
-9.8%
-283.3%
Q3 24
-29.5%
-236.6%
Q2 24
-4.3%
-266.3%
Q1 24
-19.7%
-438.9%
EPS (diluted)
ACNT
ACNT
OCUL
OCUL
Q4 25
$-0.11
$-0.27
Q3 25
$-0.22
$-0.38
Q2 25
$0.65
$-0.39
Q1 25
$-0.23
$-0.38
Q4 24
$-0.11
$-0.25
Q3 24
$-0.61
$-0.22
Q2 24
$-0.09
$-0.26
Q1 24
$-0.54
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$57.6M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$654.3M
Total Assets
$111.9M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
OCUL
OCUL
Q4 25
$57.6M
$737.1M
Q3 25
$58.0M
$344.8M
Q2 25
$60.5M
$391.1M
Q1 25
$14.3M
$349.7M
Q4 24
$16.1M
$392.1M
Q3 24
$8.5M
$427.2M
Q2 24
$3.6M
$459.7M
Q1 24
$1.3M
$482.9M
Total Debt
ACNT
ACNT
OCUL
OCUL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
OCUL
OCUL
Q4 25
$87.0M
$654.3M
Q3 25
$87.1M
$258.2M
Q2 25
$89.7M
$305.9M
Q1 25
$91.2M
$265.9M
Q4 24
$93.5M
$315.3M
Q3 24
$94.7M
$352.0M
Q2 24
$101.0M
$377.7M
Q1 24
$102.0M
$408.0M
Total Assets
ACNT
ACNT
OCUL
OCUL
Q4 25
$111.9M
$808.1M
Q3 25
$119.9M
$410.9M
Q2 25
$122.6M
$451.3M
Q1 25
$152.5M
$405.9M
Q4 24
$147.3M
$457.9M
Q3 24
$148.6M
$490.4M
Q2 24
$158.2M
$517.1M
Q1 24
$161.0M
$538.9M
Debt / Equity
ACNT
ACNT
OCUL
OCUL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
OCUL
OCUL
Operating Cash FlowLast quarter
$266.0K
$-54.2M
Free Cash FlowOCF − Capex
$-196.0K
$-57.1M
FCF MarginFCF / Revenue
-1.7%
-430.9%
Capex IntensityCapex / Revenue
3.9%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
OCUL
OCUL
Q4 25
$266.0K
$-54.2M
Q3 25
$1.3M
$-50.7M
Q2 25
$-1.4M
$-55.2M
Q1 25
$-700.0K
$-44.7M
Q4 24
$8.8M
$-39.4M
Q3 24
$3.4M
$-36.6M
Q2 24
$2.2M
$-24.8M
Q1 24
$263.0K
$-33.9M
Free Cash Flow
ACNT
ACNT
OCUL
OCUL
Q4 25
$-196.0K
$-57.1M
Q3 25
$695.0K
$-56.7M
Q2 25
$-1.5M
$-56.5M
Q1 25
$-1.0M
$-46.6M
Q4 24
$8.4M
$-39.6M
Q3 24
$3.1M
$-36.6M
Q2 24
$1.9M
$-25.5M
Q1 24
$25.0K
$-34.1M
FCF Margin
ACNT
ACNT
OCUL
OCUL
Q4 25
-1.7%
-430.9%
Q3 25
3.5%
-390.0%
Q2 25
-8.3%
-419.7%
Q1 25
-4.1%
-435.6%
Q4 24
80.6%
-232.0%
Q3 24
15.1%
-237.6%
Q2 24
9.1%
-155.4%
Q1 24
0.1%
-231.1%
Capex Intensity
ACNT
ACNT
OCUL
OCUL
Q4 25
3.9%
21.4%
Q3 25
3.1%
41.2%
Q2 25
0.8%
9.3%
Q1 25
1.3%
18.1%
Q4 24
3.7%
1.2%
Q3 24
1.3%
0.6%
Q2 24
1.0%
4.5%
Q1 24
0.9%
1.7%
Cash Conversion
ACNT
ACNT
OCUL
OCUL
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons